Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Release

European life sciences sector embraces home-working: 37% work from home at least once a week

Hobson Prior
Posted on: 11 Oct 16
European life sciences sector embraces home-working: 37% work from home at least once a week

London, UK, 11th October 2016 / Sciad Newswire / According to new research from specialist recruiter Hobson Prior, home-working is growing ever more popular in the life sciences sector: 32% of professionals surveyed have seen an increase in the number of home-working opportunities available. Almost three quarters of these individuals reported working from home at least occasionally, 37% do so at least one day per week, and 11% are fully home-based.  

Career trends in life sciences surveyed 1,527 individuals working in the European life sciences industry. Focusing on skills shortage and its impact on careers, the report suggests employers are increasingly acknowledging the usefulness of home-working as a way to reduce overheads, recruit remote workforces, and attract and retain top talent.

The benefits for employees are manifold. “Working from home can promote a healthier work-life balance, as well as creating a greater sense of trust and autonomy,” comments Jake Thomas, Managing Director of Hobson Prior. “Some people feel it makes them much more productive too.”

According to the report, flexible working is most common in the Netherlands, with 70% working from home at least occasionally. Yet Spain has the most professionals who are completely home-based (34%), and an impressive 48% of French respondents say they work from home at least one day per week. France has long been ahead of the curve in promoting work-life balance, and its consultancies are now banned from asking staff to check emails outside of 9am-6pm. The UK sits just above average, with 39% working from home at least one day per week.

Conversely, Ireland has the highest percentage of respondents who never or rarely work from home (63%), as well as the lowest percentage that have seen an increase in home-working opportunities (14%).

Those in clinical operations and clinical research and development are the most likely to work mostly from home. “Home-working can really suit CRAs and CPMs, as their work allows much of their interaction with colleagues to be done remotely,” explains James Inwood, Hobson Prior’s Clinical Team Leader. “It’s certainly becoming more common in CROs, which aim to cut costs by reducing office-based staff.”

Yet although a more cost-efficient and content workforce may sound appealing, the report warns employers to ensure the appropriate infrastructure is in place before encouraging employees to work from home. On the subject, one respondent commented: “Home-working requires a good attitude from colleagues, management skills from managers and technical support for the employee.”

Without these fundamentals, home working can quickly lead to employees feeling isolated and lacking control, with one respondent commenting: “In my last company I was completely home-based, but with no support or integration I decided I would rather leave and commute to another country instead.”

ENDS

Visit www.hobsonprior.com/career-trends-report or contact HPMediaEnquiries@hobsonprior.com for more information and to obtain a full copy of Career trends in life sciences. Hobson Prior is a leading life sciences recruitment consultancy, focused on finding and placing outstanding candidates across Europe, Asia Pacific and the United States.

Editor's Details

Emma Pickup

Last updated on: 11/10/2016

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.